469 related articles for article (PubMed ID: 28213378)
1. Prognostic role of circulating exosomal miRNAs in multiple myeloma.
Manier S; Liu CJ; Avet-Loiseau H; Park J; Shi J; Campigotto F; Salem KZ; Huynh D; Glavey SV; Rivotto B; Sacco A; Roccaro AM; Bouyssou J; Minvielle S; Moreau P; Facon T; Leleu X; Weller E; Trippa L; Ghobrial IM
Blood; 2017 Apr; 129(17):2429-2436. PubMed ID: 28213378
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
[TBL] [Abstract][Full Text] [Related]
3. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
4. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
5. Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma.
Luo Y; Gui R
Turk J Haematol; 2020 Nov; 37(4):248-262. PubMed ID: 32812415
[TBL] [Abstract][Full Text] [Related]
6. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L
Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540
[TBL] [Abstract][Full Text] [Related]
7. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
[TBL] [Abstract][Full Text] [Related]
8. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer.
Huang X; Yuan T; Liang M; Du M; Xia S; Dittmar R; Wang D; See W; Costello BA; Quevedo F; Tan W; Nandy D; Bevan GH; Longenbach S; Sun Z; Lu Y; Wang T; Thibodeau SN; Boardman L; Kohli M; Wang L
Eur Urol; 2015 Jan; 67(1):33-41. PubMed ID: 25129854
[TBL] [Abstract][Full Text] [Related]
11. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
Liu X; Chu KM
J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554
[TBL] [Abstract][Full Text] [Related]
13. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
14. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
Zhang ZY; Li YC; Geng CY; Zhou HX; Gao W; Chen WM
Hematol Oncol; 2019 Oct; 37(4):409-417. PubMed ID: 31102419
[TBL] [Abstract][Full Text] [Related]
15. Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma.
Zhang ZY; Li YC; Geng CY; Wang HJ; Chen WM
Biomed Res Int; 2019; 2019():1575468. PubMed ID: 31915680
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma.
Cao D; Cao X; Jiang Y; Xu J; Zheng Y; Kang D; Xu C
Hematol Oncol; 2022 Apr; 40(2):172-180. PubMed ID: 34874565
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
[TBL] [Abstract][Full Text] [Related]
18. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
Dai D; Tan Y; Guo L; Tang A; Zhao Y
Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
20. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma.
Que R; Ding G; Chen J; Cao L
World J Surg Oncol; 2013 Sep; 11():219. PubMed ID: 24007214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]